velsecorat: Clinical Trials

1 trial of velsecorat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow velsecorat: new trials by email Literature Review of velsecorat trials Research Report on velsecorat

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma
800 μg AZD7594 once daily, 250 µg AZD7594 once daily, 58 µg AZD7594 once daily - Asthma, Efficacy
Phase 2CompletedAstraZeneca542015-06-252018-02-15

Conditions studied

Asthma (1)

Sponsors

AstraZeneca (1)

Countries

Bulgaria (1)  ·  Germany (1)

Top investigators

Andrea Ludwig-Sengpiel, Dr. (1)  ·  Anne-Marie Kirsten, Dr. (1)  ·  Anneliese Linnhoff, Dr. med. (1)  ·  Christine Grigat, Dr. (1)  ·  Dirk Skowasch, Prof. (1)  ·  Jutta Beier, Dr. med. (1)  ·  Margret Jandl, Dr. (1)  ·  Oliver Kornmann, Dr. (1)  ·  Rainard Fuhr, Dr. med. (1)  ·  Tanya Kralimarkova, Dr. (1)  ·  Ulrike Westerhausen, Dr. (1)

Results publications

PMID 30777086

NIH funding

2014 (1)